B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

DAPK1

MOLECULAR TARGET

death associated protein kinase 1

UniProt: P53355NCBI Gene: 161221 compounds

DAPK1 (death associated protein kinase 1) is targeted by 21 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting DAPK1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1morin4.2871
2ruxolitinib4.2368
3pi 1034.1764
4bi 25364.0154
5midostaurin3.8546
6tae 6843.4330
7fedratinib3.4029
8sulfuretin3.1422
9athraquinones a3.1422
10lestaurtinib3.0420
11ruboxistaurin2.9418
12r 4062.8316
13gossypetin2.8316
14kw 24492.6413
15gsk 6906932.6413
16purpurin2.6413
17gsk 4613642.4010
18su 0148132.208
19Kaempferols0.691
20Quercetin0.691
21pictilisib0.691

About DAPK1 as a Drug Target

DAPK1 (death associated protein kinase 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 21 compounds with documented DAPK1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

DAPK1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.